Use of a combination of ethinyloestradiol and chlormadinone acetate to produce a pharmaceutical preparation
The invention relates to the use of a combination of ethinyloestradiol and chlormadinone acetate to produce a pharmaceutical preparation for the treatment of androgen-induced disorders and for hormone replacement therapy and for the treatment of dysmenorrhoea and for stabilising the menstrual cycle...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
01.12.2005
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to the use of a combination of ethinyloestradiol and chlormadinone acetate to produce a pharmaceutical preparation for the treatment of androgen-induced disorders and for hormone replacement therapy and for the treatment of dysmenorrhoea and for stabilising the menstrual cycle and for the treatment of menstrual cycle-dependent complaints and for contraception simultaneously in women. |
---|---|
Bibliography: | Application Number: US20040009361 |